A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells

Zhaoxia Zhang1, Thomas J Knobloch, Leigh G Seamon

  • 1College of Public Health, The Ohio State University, Columbus, OH, USA.

Gynecologic Oncology
|August 12, 2011
PubMed
Abstract

Insights

Black raspberries inhibit human cervical cancer cell growth and induce apoptosis. This study suggests black raspberries are promising for phytochemical-based cancer prevention strategies.

Area of Science:

  • Oncology
  • Phytochemistry
  • Cancer Biology

Background:

  • Cervical cancer is a significant global health challenge.
  • Black raspberries show promise in inhibiting epithelial cancer cell growth.
  • This research explores black raspberry chemoprevention for cervical carcinogenesis.

Purpose of the Study:

  • To investigate the effects of black raspberry extract on human cervical cancer cells.
  • To determine if black raspberries can inhibit cervical cancer cell growth and induce apoptosis.

Main Methods:

  • Three human cervical cancer cell lines (HeLa, SiHa, C-33A) were treated with black raspberry ethanol extract (RO-ET).
  • Cell proliferation was assessed using WST1 assays.
  • Apoptosis was measured via flow cytometry and fluorescence microscopy.

Main Results:

  • Non-toxic RO-ET levels significantly inhibited cervical cancer cell growth in a dose- and time-dependent manner (up to 67%).
  • Inhibition persisted after short-term withdrawal of RO-ET.
  • RO-ET induced apoptosis in all tested cell lines.

Conclusions:

  • Black raspberries and their components show potential for targeted cancer prevention.
  • Phytochemical-based strategies using black raspberries warrant further investigation for cervical cancer prevention.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...